Indefinite Delivery Contract 36E79720D0052
Award Date
9/15/20
Last Date to Order
9/14/25
Federal Agency
National Acquisition Center
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the U.S. Department of Veterans Affairs (VA), to Pfizer Inc. as the prime contractor. The single-award IDC has a ceiling value of $74,038,216.80 and a base ordering period from September 15, 2025 to September 14, 2026, with four one-year option periods. The contract is for the procurement of Rituximab and its biosimilar products to support multiple federal healthcare agencies,...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency, to Pfizer Inc. as the prime contractor. The contract has a ceiling value of $66,935,445.85 and a period of performance from October 8, 2020 to October 7, 2025, with four one-year option periods. The purpose of this IDC is to provide the U.S. federal government with a source for Epoetin vials, a critical pharmaceutical product. As one of the world's largest pharmaceutical companies, Pfizer...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Pfizer Inc., a large pharmaceutical manufacturer, with a ceiling value of $48,683,160.88. The contract, which does not utilize any small business set-asides, has an ultimate completion date of August 31, 2030. Pfizer, as the prime contractor, will be responsible for delivering a wide range of critical pharmaceutical products to support the medical needs of the Department of...
This federal Indefinite Delivery Contract (IDC) award to Pfizer Inc. is for the procurement of COVID-19 adult vaccines on behalf of the Centers for Disease Control and Prevention (CDC). The multiple-award contract has a total ceiling value of $498,550,000 and a period of performance through September 30, 2025. As the prime contractor, Pfizer will be responsible for delivering a range of pharmaceutical products to support federal healthcare programs, including the Vaccines for Children (VFC)...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency, to Pfizer Inc. to provide an uninterrupted supply of Bevacizumab (ZIRABEV) for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a 1-year base period with four 1-year option periods, for a total potential period of performance through August 12, 2025. The contract value has a ceiling of...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, with a ceiling value of $458,750,000 and a period of performance through May 31, 2026. The primary purpose of this IDC is to procure adult COVID-19 vaccines for the federal government. As a multiple award contract, this vehicle allows the CDC to issue task orders to Pfizer and potentially other vendors to fulfill specific vaccine...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs to Pfizer Inc., provides a broad range of pharmaceutical products and medications to multiple federal agencies, including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The $7.31 billion IDV contract covers a wide variety of pharmaceuticals, vaccines, medical equipment, and injectable medications, such as antibiotics,...
This federal contract IDV award is a multiple-award Indefinite Delivery Contract between the Centers for Disease Control and Prevention (CDC) and Pfizer Inc., a global pharmaceutical manufacturer. The $117,849,500 contract, with a performance period ending June 30, 2026, is for the delivery of adult vaccines under the CDC's VACCINES program. As the prime contractor, Pfizer will provide a range of pharmaceutical products to multiple federal healthcare agencies, including the Department of...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Pfizer Inc., a large pharmaceutical manufacturer, to support the Vaccines for Children (VFC) program. The $2,208,581,100 contract, which spans April 1, 2025 through March 30, 2026, will provide a range of standard commercial pediatric vaccines to eligible children, including those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or have...
This federal contract IDV award is for the provision of Bevacizumab injections to support multiple federal healthcare organizations, including the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract was awarded to Pfizer Inc. as the single prime contractor, with a ceiling value of $46,893,140.00 and a total ordering period from August 13, 2025 to August 12, 2026, with four additional one-year...